You have 9 free searches left this month | for more free features.

Sign in for free

Phase

phase 2 (482)

phase 1 (176)

phase 3 (95)

phase 1/phase 2 (84)

n/a (51)

phase 4 (22)

phase 2/phase 3 (15)

early phase 1 (3)

Study Documents

Funder Type

Other (710)

Industry (251)

NIH (65)

U.S. Fed (1)

Study Type

Interventional (928)

Observational (86)

Observational [Patient Registry] (10)

Expanded Access (3)

Erlotinib

Showing 1026 - 1027 of 1,027

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC, Tumor Metastasis Trial in Tel Aviv (Erlotinib, Temozolomide)

Unknown status

Carcinoma, Non-Small-Cell Lung
Neoplasm Metastasis

Erlotinib, Temozolomide

Tel Aviv, Israel

Tel Aviv Sourasky Medical Center

Feb 27, 2006

Colorectal Cancer Trial in Indianapolis, Baltimore, Dallas (Erlotinib (aka Tarceva or OSI-774), Bevacizumab (aka Avastin or Rhu

Completed

Colorectal Cancer

Erlotinib (aka Tarceva or OSI-774)
Bevacizumab (aka Avastin or Rhu MAb VEGF)

Indianapolis, Indiana
+2 more

Jun 23, 2005